Medpace Holdings, Inc. (MEDP)
NASDAQ
Healthcare
Medical - Diagnostics & Research
$601.38
▼ -0.73%
Market Cap
$16.79B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.15
52-Wk Range
373-677.9
CEO
August James Troendle
Country
US
Currency
USD
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, oversee…
Open full interactive analysis & DCF →